Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 19 EP applications Savroop Purewal has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12744016

ANTIBACTERIAL HOMOPIPERIDINYL SUBSTITUTED 3,4 DIHYDRO 1H [1,8]NAPHTHYRIDINONES

IPC classification:
A61K 31/4375, C07D 471/04, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Applicant:
Janssen Research & Development Ireland
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP12746093

ANTIBACTERIAL CYCLOPENTA[C]PYRROLE SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES

IPC classification:
A61K 31/4375, C07D 487/04, C07D 471/04, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Applicant:
Janssen Research & Development Ireland
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP12750575

ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES

IPC classification:
A61K 31/4375, C07D 471/04, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Applicant:
Janssen Research & Development Ireland
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP12762583

PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV

IPC classification:
C07D 453/04, C07D 417/04, C07D 311/06
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP12790677

IMPROVED PROCESS FOR PREPARING AN INTERMEDIATE OF THE MACROCYCLIC PROTEASE INHIBITOR TMC 435

IPC classification:
C07D 417/14
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14170114

HIV inhibiting 5,6-substituted pyrimidines

IPC classification:
A61K 31/506, A61K 31/505, C07D 417/06, C07D 409/12, C07D 409/04, C07D 405/12, C07D 405/04, C07D 401/12, C07D 401/06, C07D 401/04, C07D 239/48, A61P 31/18
Applicant:
Janssen Sciences Ireland UC
Applicant:
Janssen Research & Development Ireland
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13719524

ANTIBACTERIAL QUINOLINE DERIVATIVES

IPC classification:
A61K 31/4709, C07D 401/06, A61P 31/06
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13720875

ANTIBACTERIAL QUINOLINE DERIVATIVES

IPC classification:
A61K 31/4709, C07D 401/14, C07D 401/06, A61P 31/06
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13747399

NEW ANTIBACTERIAL COMPOUNDS

IPC classification:
A61K 31/551, C07D 519/00, C07D 498/14, C07D 498/04, C07D 471/14, C07D 471/04, C07D 417/14, C07D 409/14, C07D 405/12, C07D 401/14, C07D 401/12, C07D 401/06, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP13762752

NEW ANTIBACTERIAL COMPOUNDS

IPC classification:
A61K 31/5513, A61K 31/55, C07D 513/14, C07D 498/14, C07D 498/04, C07D 471/04, C07D 413/14, C07D 405/14, C07D 401/14, C07D 401/06, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP15158049

Macrocylic inhibitors of hepatitis c virus

IPC classification:
A61K 45/06, A61K 38/21, A61K 38/05, A61K 31/4709, A61K 31/427, C07D 487/04, C07D 417/14, C07D 417/04, C07D 277/56, C07D 245/04, C07C 211/45
Applicant:
Janssen Sciences Ireland UC
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP13722329

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES

IPC classification:
A61K 31/506, A61K 31/505, C07D 409/14, C07D 405/14, C07D 403/04, C07D 401/04, C07D 239/42, C07D 239/26, A61P 31/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14708885

PROCESSES AND INTERMEDIATES FOR PREPARING A MEDICAMENT

IPC classification:
A61P 35/00, A61P 29/00, A61K 31/519, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP16195560

AMORPHOUS SALT OF A MACROCYCLIC INHIBITOR OF HCV

IPC classification:
A61P 31/14, A61K 31/4725, A61K 31/47, A61K 9/14, C07D 417/14, C07D 417/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP17166514

PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV

IPC classification:
C07C 51/487
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16701516

DISPERSIBLE COMPOSITIONS

IPC classification:
A61K 31/00, A61K 9/20, A61K 9/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16715347

PROCESSES AND INTERMEDIATES FOR PREPARING A MACROCYCLIC PROTEASE INHIBITOR OF HCV

IPC classification:
C07C 231/12, C07C 231/02, C07D 417/14, C07D 417/04, C07C 67/60, C07C 67/31, C07C 67/30, C07C 67/08
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16734637

ANTIBACTERIAL COMPOUNDS

IPC classification:
C07D 403/12, C07D 519/00, C07D 513/04, C07D 487/10, C07D 487/04, C07D 471/04, A61K 31/519, A61K 31/438, A61K 31/437, A61K 31/429, C07D 401/12, A61P 31/04, A61P 31/06
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16733105

ANTIBACTERIAL COMPOUNDS

IPC classification:
A61K 31/498, A61K 31/4709, C07D 401/14, C07D 513/04, C07D 487/04, C07D 471/04, A61P 31/06
Agent:
Savroop Purewal, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature